Linda Zhao, OD
Optometrist · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Zhao’s office at (408) 848-9400 to ask if they take your plan before you enroll.
California Medical Board record
Licence G14968 · Deceased
Licence status: Deceased · since 1968 · State University of New York at Buffalo School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$165,239 in 2024
Medicaid paid $165,239 for 3,358 billed services this clinician did in 2024, up to 81 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 760 | $157,995 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 199 | $1,738 |
| Short return visit (20+ min) | 954 | $1,723 |
| Fitting of monofocal spectacles | 276 | $1,260 |
| Frames, purchases | 281 | $1,017 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 84 | $918 |
| DETERMINATION REFRACTIVE STATE | 791 | $557 |
| Short return visit | 13 | $31 |
| 2024 | 3,358 | 8 | 81 | $165,239 |
| 2023 | 2,824 | 9 | 70 | $139,610 |
| 2022 | 165 | 6 | 46 | $9,891 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 658 | $131,784 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 292 | $2,266 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 164 | $2,057 |
| Fitting of monofocal spectacles | 337 | $1,493 |
| Frames, purchases | 337 | $1,122 |
| DETERMINATION REFRACTIVE STATE | 753 | $621 |
| Short return visit (20+ min) | 209 | $216 |
| Short return visit | 42 | $31 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 32 | $20 |
2022
| Clinic visit/encounter, all-inclusive | 47 | $9,394 |
| Fitting of monofocal spectacles | 25 | $116 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 14 | $107 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $107 |
| Frames, purchases | 30 | $96 |
| DETERMINATION REFRACTIVE STATE | 35 | $72 |
Drugs they prescribed that Part D paid
$6,595
Pharmacies billed $6,595 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 21) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
11 generic and fewer than 11 brand-name prescriptions · $6,595 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 21 | None | 0% (0) | None | $6,595 |
| 2022 | 24 | None | 0% (0) | 54% | $7,155 |
| 2021 | 34 | 12 | 0% (0) | 68% | $9,986 |
| 2020 | 40 | 11 | 0% (0) | 43% | $7,784 |
| 2019 | 37 | None | 0% (0) | 81% | $13,664 |
| 2018 | 25 | None | 0% (0) | 60% | $5,409 |
| 2017 | 26 | None | 0% (0) | None | $321 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Restasis Multidose | 12 | $6,040 | $503 |
2019: 1 drug
| Restasis | 15 | $8,219 | $548 |
2017: 1 drug
| Latanoprost | 19 | $222 | $12 |
Money from drug and device companies
$34 in 2021
| 2021 | 1 | 2 | None | $34 |
| 2020 | 2 | 2 | None | $37 |
| 2019 | 2 | 2 | None | $242 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CooperVision | Multiple Brands Contact Lens | $34 | 2 payments
|
See all 2 published payments
| CooperVision | Meals · 2021-02-16 | Misight Contact Lens | $14 |
| CooperVision | Meals · 2021-02-04 | Multiple Brands Contact Lens | $20 |
See earlier years (2020, 2019)
2020: $37
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $242
| Shire North American Group | Xiidra | $125 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Ultra | $118 | 1 payment
|
Professional record
- NPI
- 1194139600
- Licence
- CA 14968California G14968: Deceased
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 7526 Monterey St, Gilroy, CA, 95020
- NPI first listed
- 2014-06-12
- NPI last updated
- 2017-04-16
This is when the NPI record was last certified, not a medical board exam.